Ortoma AB Logo

Ortoma AB

ISIN

SE0005676103

Ticker

ORT

Sector

Health Care

Sub-Industry

Health Care Equipment

Country

Sweden

Year Founded

2001

About Ortoma AB

Company Description

CONTROLLABLE TREATMENT SOLUTIONS WITH CUTTING EDGE TECHNOLOGY

Orthopaedic surgical procedures involve several challenging steps and many technical components. Ortoma’s goal is to improve patients’ lives by developing efficient, innovative products to support surgeons so they can provide the best possible outcome for their patients while keeping them in control of the entire process.

The connection between art, science, and medicine exists since the beginning of time and curiosity is its driving force. Ortoma believes that improving medical science comes with using cutting-edge technology. That philosophy is what inspired Ortoma to develop products to improve the patient’s quality of life. We focus on developing technology solutions for orthopaedics procedures. In 2011, Ortoma initiated the development of a 3D pre-operative planning platform for orthopaedics procedures with hip replacement surgery as the first priority.

Headcount

4

Served Area

Europe

Headquarters

Erik Dahlbergsgatan 11A
41126, Goeteborg
Sweden

Insider Trades

Date Trading entity / Person Association Trade type Volume
30.01.2024 Peter Möller Other Buy SEK 600,000.00
29.01.2024 Matts Andersson Other Sell SEK 600,000.00
28.11.2023 Peter Möller Other Other SEK 17,618,179.50
28.11.2023 Peter Möller Other Other SEK 1,761,815.40
20.02.2023 Yvonne Mårtensson Other Buy SEK 5,980.00
06.10.2021 Peroso AB Other Buy SEK 1,095,126.79
09.09.2021 Magnus Yngen Other Buy SEK 394,000.00
19.03.2021 Roy Forslund Other Other SEK 0.00
08.03.2021 Peter Möller Other Buy SEK 903,170.00
05.03.2021 Linus Byström Other Buy SEK 65,536.80

Capital Markets Information

ISIN

SE0005676103

LEI

549300YX458MQ26P4W97

Listed Stock Exchange

Nasdaq Nordic

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.